Last reviewed · How we verify
NCT04783220: PREPARE
PaREnting ProgrAm to Enhance PREterm Infants' Health and Development (PREPARE Trial)
NA trial testing Comprehensive structured parent intervention in Behavioral Assessment of Children in 72 participants. Participants enrolled and being followed up; not accepting new ones.
14 October 2024
Quick facts
| Lead sponsor | American University of Beirut Medical Center |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 72 |
| Start date | 1 November 2021 |
| Primary completion | 14 October 2024 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across Lebanon |
Drugs / interventions tested
- Comprehensive structured parent intervention
Conditions studied
- Behavioral Assessment of Children — all drugs for Behavioral Assessment of Children →
- Early Intervention — all drugs for Early Intervention →
Sponsor
American University of Beirut Medical Center
Who can join
Adults 1 Day to 21 Days, any sex, with Behavioral Assessment of Children or Early Intervention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Preterm infants are at high risk of developmental delay or disabilities and they do benefit from early intervention programs. Many programs aiming at improving preterm infants' developmental outcome have been proposed with mixed results. In low to middle-income countries, clinically relevant and effective low cost interventions empowering parents have yet to be established.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04783220
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other American University of Beirut Medical Center trials
Trials by the same sponsor.
- NCT07387848 — Glofitamab as a Bridge to and/or Consolidation Post Autologous Stem Cell Transplant in Patients With Relapsed B Cell Lym · Phase 2 · not yet recruiting
- NCT07111000 — Testing the Epley Maneuver for Treating Dizziness in the Emergency Department: A Randomized Study · NA · not yet recruiting
- NCT07059624 — Femoral Arterial Cannulation in Pediatrics · NA · recruiting
- NCT06777875 — COMT and OPRM1 Polymorphisms and Their Effect on Post-Operative Pain in Children · recruiting
- NCT06815952 — Enhancing Difficult Laryngoscopy Prediction Through A Mixed Scoring System · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04783220 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by American University of Beirut Medical Center
- Last refreshed: 4 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04783220.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing